Literature DB >> 26195563

Pregnancy outcome for fetuses with increased nuchal translucency but normal karyotype.

Christina Unger Lithner1, Marius Kublickas2, Sverker Ek3.   

Abstract

OBJECTIVE: To investigate pregnancy outcome for fetuses with nuchal translucency (NT) ≥3.5 mm but normal karyotype in the Stockholm (Sweden) area.
METHODS: A retrospective population-based cohort study. From 2006 to 2012, fetal NT was measured in 55123 singleton pregnancies. There were 341 pregnancies with NT thickness ≥3.5 mm; 139 had a normal karyotype, 164 had an abnormal karyotype and 38 were removed from the study. Pregnancy outcome was defined as adverse (termination of pregnancy [TOP], miscarriage [MC], intrauterine fetal death [IUFD], or delivery of a child with structural defects or genetic disorders), or favourable (delivery of a child without any structural defects or genetic disorders diagnosed before discharge).
RESULTS: Of the 139 high NT pregnancies with normal karyotype, 110 (79.2%) resulted in live births, one (0.7%) IUFD, 23 (16.5%) TOP and five (3.6%) MC. The risk of an adverse pregnancy outcome increased with increasing NT. Structural fetal defects were found in 28 (19.5%) of pregnancies undergoing second trimester ultrasound screening, of which seven resulted in live births and 21 were terminated. The most common structural defect was cardiac defects.
CONCLUSIONS: Adverse pregnancy outcome increased with increasing NT, even with normal karyotype, however, the prognosis is good if the second trimester ultrasound screening is normal.
© The Author(s) 2015.

Entities:  

Keywords:  Congenital defect; Karyotype; Nuchal translucency; Pregnancy outcome; Prenatal Diagnosis

Mesh:

Year:  2015        PMID: 26195563     DOI: 10.1177/0969141315595826

Source DB:  PubMed          Journal:  J Med Screen        ISSN: 0969-1413            Impact factor:   2.136


  7 in total

1.  Pregnancy Outcome of Abnormal Nuchal Translucency: A Systematic Review.

Authors:  Nasibeh Roozbeh; Maryam Azizi; Leili Darvish
Journal:  J Clin Diagn Res       Date:  2017-03-01

2.  Increased nuchal translucency before 11 weeks of gestation: Reason for referral?

Authors:  Malou A Lugthart; Bo B Bet; Fleur Elsman; Karline van de Kamp; Bernadette S de Bakker; Ingeborg H Linskens; Merel C van Maarle; Elisabeth van Leeuwen; Eva Pajkrt
Journal:  Prenat Diagn       Date:  2021-10-08       Impact factor: 3.242

3.  Fetal nuchal translucency: is there an association with birthweight and neonatal wellbeing?

Authors:  Ziya Kalem; Aşkı Ellibeş Kaya; Batuhan Bakırarar; Müberra Namlı Kalem
Journal:  Turk J Obstet Gynecol       Date:  2019-03-27

4.  Increased nuchal translucency and pregnancy outcomes: experience of Başkent University Ankara Hospital.

Authors:  Nihal Şahin Uysal; Çağrı Gülümser; Zerrin Yılmaz Çelik; Filiz Bilgin Yanık
Journal:  Turk J Obstet Gynecol       Date:  2019-07-03

5.  High Frequency of Fetal Loss in Fetuses With Normal Karyotype and Nuchal Translucency ≥ 3 Among the Iranian Pregnant Women.

Authors:  Shokoh Abotorabi; Niloufar Moeini; Sahar Moghbelinejad
Journal:  J Family Reprod Health       Date:  2020-06

6.  Different Cutoff Values for Increased Nuchal Translucency in First-Trimester Screening to Predict Fetal Chromosomal Abnormalities.

Authors:  Linjuan Su; Xiaoqing Wu; Na Lin; Xiaorui Xie; Meiying Cai; Meiying Wang; Lin Zheng; Liangpu Xu
Journal:  Int J Gen Med       Date:  2021-11-18

7.  Chromosomal microarray analysis versus noninvasive prenatal testing in fetuses with increased nuchal translucency.

Authors:  Chaohong Wang; Junxiang Tang; Keting Tong; Daoqi Huang; Huayu Tu; Jiansheng Zhu
Journal:  J Hum Genet       Date:  2022-05-17       Impact factor: 3.755

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.